🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 49 of 78

  1. US 8217158

    Immunotoxin fusion proteins and means for expression thereof

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8211447

    Recombinant P. falciparum merozoite protein-142 vaccine

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8211445

    PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8211422

    Chimeric receptor genes and cells transformed therewith

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8206933

    Boris isoforms and methods of detecting and treating disease

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8207142

    Inhibitor of DNA methylation

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8202551

    Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8202520

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8198244

    Regulation of skin characteristics by DICKKOPF1 (DKK1)

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8198402

    Smoothened polypeptides and methods of use

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8198042

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8193167

    Pharmacologically active agents containing esterified phosphonates and methods for use thereof

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8188055

    Inactivators of O6-alkylguanine-DNA alkyltransferase

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8188214

    Brachyury polypeptides and methods for use

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8183358

    Puumala virus full-length M segment-based DNA vaccines

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8182842

    Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8178508

    Methods of stimulating an immune response against prostate specific antigen

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8173135

    Methods for preparing complex multivalent immunogenic conjugates

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8173139

    High energy electron beam irradiation for the production of immunomodulators in poultry

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8173123

    Methods of treating colitis involving IL-13 and NK-T cells

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8168604

    Antisense antiviral compounds and methods for treating a filovirus infection

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8168202

    Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8168195

    Vaccines against Escherichia coli O157 infection

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8163545

    Vaccine against pandemic strains of influenza viruses

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8163309

    Starch foam microparticles

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8163542

    Potent combinations of mRNA transport elements

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8158592

    Immunostimulatory nucleic acid molecules

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8158603

    Fragments of secreted frizzled related protein

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8153156

    Hydrogel nanocompsites for ophthalmic applications

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8153781

    Dendrimer conjugates of agonists and antagonists of the GPCR superfamily

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8148323

    Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8147840

    Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8148340

    Immunomodulatory oligonucleotides

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8143308

    Synthesis of oligo/poly(catechins) and methods of use

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8142787

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8143252

    Tetrahalogenated compounds useful as inhibitors of angiogenesis

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8137960

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8133917

    Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8133495

    Live attenuated antigenically marked classical swine fever virus

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8133859

    SCGB3A2 as a growth factor and anti-apoptotic agent

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8129351

    Immunostimulatory nucleic acid molecules

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8124592

    Development of a preventive vaccine for filovirus infection in primates

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8125225

    Transmit profile control in MRI

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8124105

    Compositions, methods and kits relating to poxvirus subunit vaccines

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8124101

    Genetically engineered swine influenza virus and uses thereof

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8119642

    Structurally rigid dopamine D3 receptor selective ligands and process for making them

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8114852

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8114848

    Immunomodulatory oligonucleotides

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.